ArticleMethodsX2025
Design of an iterative hybrid multimodal deep learning method for early skin disease detection with cross-attention and graph-based fusions.
Article in MethodsX, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Hybrid vision transformer and graph neural network model with region-adaptive attention for enhanced skin cancer prediction.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study proposes an end-to-end multimodal learning framework for early skin disease detection, incorporating both their spatial, temporal, and semantic information across heterogeneous patient data. The framework is composed of three key modules: (i)EfficientNet-B4 that extracts rich visual features from dermoscopic images, (ii) aBiLSTM enhanced with temporal attentionto model symptom evolvement from sensor-based time-series signals, and (iii) ClinicalBERT, a domain-specific transformer that generates contextual embeddings from patient clinical narratives. Modality-specific features are combined with a multi-head cross-attention mechanism to aggregate inter-dependency of input patterns and then fed into a Graph Attention Network (GAT) to capture inter-patient relationships according to feature affinity. This joint framework produces context-aware representations that can be used for classification. Experimental results show that the model can achieve predictive accuracy of 89.6 % and F1-score of 0.886 on average, which is superior to the state-of-the-art CNN-based baselines. Through simultaneously optimizing spatial detail, temporal dynamics, and clinical context, the Proposed SkinHarmoNet Model provides reliable and interpretable predictions, and its performance establishes the new state-of-the-art for multimodal dermatologic AI in a clinical setting.•Multimodal fusion: spatial, temporal, and semantic Modalities•Cross-attention and GAT: enhanced interaction of features•High performance: 89.6\ % accuracy, F1= 0.886.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.